Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus
Diabetic Medicine · 2024
DOI: 10.1111/dme.15383 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetic Medicine, 2024. Verfasst von SophieAnne Buckley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Metabolism, The Royal London Hospital, London, UK. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Kidney Transplantation, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.
- Department of Diabetes and Metabolism, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Centre for Obesity Research, University College, London, UK.
- Department of Nephrology, The Royal London Hospital, London, UK.
ORCID-Profile: Tahseen A Chowdhury
Zitieren
APA
Buckley, S., Subramaniam, Y., Mallik, R., Mukuba, D., Casabar, M., Ali, O., Byrne, C., & Chowdhury, T. A. (2024). Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus. Diabetic Medicine. https://doi.org/10.1111/dme.15383
Vancouver
Buckley S, Subramaniam Y, Mallik R, Mukuba D, Casabar M, Ali O, et al. Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus. Diabetic Medicine. 2024. doi:10.1111/dme.15383
BibTeX
@article{Buckley2024,
author = {Buckley, SophieAnne and Subramaniam, Yuvanaa and Mallik, Ritwika and Mukuba, Dorcas and Casabar, Mahalia and Ali, Omer and Byrne, Connor and Chowdhury, Tahseen A},
title = {Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15383}
}
EUVIMED